Expert consensus on population-based BRCA germline mutation screening in China (2024 edition)

Expert consensus on population-based BRCA germline mutation screening in China (2024 edition)

Germline mutations in BRCA genes (including BRCA1/2) are the major risk factors for hereditary tumors including breast and ovarian cancer. Population based BRCA gene screening, particularly in high-risk individuals with a family history of cancer, can play a preventive role by reducing mortality and...

Full description

Bibliographic Details
Main Author: China Anti-Cancer Association Tumor Biomarker Professional Committee, Shanghai Anti-Cancer Association Tumor Biomarker Professional Committee
Format: Article
Language:English
Published: Editorial Office of China Oncology 2024-02-01
Series:Zhongguo aizheng zazhi
Subjects:
|expert consensus|brca1|brca2|homologous recombination|mutation screening|next-generation sequencing|germline mutation
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1710376770040-43245883.pdf

Internet

http://www.china-oncology.com/fileup/1007-3639/PDF/1710376770040-43245883.pdf

Similar Items